ClinicalTrials.gg

Program

Diclofenac Sodium Gel

Also written as “Diclofenac sodium gel 1%”, “Voltaren Gel” and “Diclofenac sodium gel”.

Its studies are mostly in Keratosis, Actinic · Osteoarthritis, Knee · Osteoarthritis · Pain · Myalgia, led by 8 companies.

Furthest: phase 4, since Sep 13, 200511 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Novartis30 open or runningphase 3since Sep 13, 2005Sep 13, 2005none ahead
Amzell20 open or runningphase 1since Jul 7, 2023Jul 7, 2023none ahead
Akorn10 open or runningphase 3since Sep 22, 2016Sep 22, 2016none ahead
Encube Ethicals Pvt.10 open or runningphase 3since Jan 30, 2019Jan 30, 2019none ahead
Glenmark Pharmaceuticals Ltd. India10 open or runningphase 3since Nov 3, 2015Nov 3, 2015none ahead
HALEON10 open or runningphase 4since Apr 18, 2024Apr 18, 2024none ahead
Sun Pharmaceutical Industries10 open or runningphase 1since Dec 3, 2012Dec 3, 2012none ahead
Viatris10 open or runningphase 3since May 30, 2017May 30, 2017none ahead

Also a collaborator on its studies: Novum Pharmaceutical Research Services.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 13, 2005First study: phase 3 study in OsteoarthritisNew to NovartisNovartis · NCT00171652 · 360 enrolled · France, Germany
  2. Jan 24, 2007Phase 3 study in Osteoarthritis, KneeNovartis · NCT00426621 · 420 enrolled · United States
  3. Dec 3, 2012Sun Pharmaceutical Industries’ first study: phase 1 study in Keratosis, ActinicNew to Sun Pharmaceutical IndustriesSun Pharmaceutical Industries · NCT01742663 · 435 enrolled
  4. Oct 20, 2014Phase 3 study in MyalgiaNovartis · NCT02271854 · 102 enrolled · United States
  5. Nov 3, 2015Glenmark Pharmaceuticals Ltd. India’s first study: phase 3 study in OsteoarthritisNew to Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals Ltd. India · NCT02596451 · 1,164 enrolled · United States
  6. Sep 22, 2016Akorn’s first study: phase 3 study in Osteoarthritis, KneeNew to AkornAkorn · NCT02913521 · 934 enrolled · Estonia, Latvia, Lithuania and more
  7. May 30, 2017Viatris’s first study: phase 3 study in Osteoarthritis, KneeNew to ViatrisViatris · NCT03172780 · 1,220 enrolled · India
  8. Jan 30, 2019Encube Ethicals Pvt.’s first study: phase 3 study in Keratosis, ActinicNew to Encube Ethicals Pvt.Encube Ethicals Pvt. · NCT03826550 · 655 enrolled · United States
  9. Jul 7, 2023Amzell’s first study: phase 1 study in HealthyNew to AmzellAmzell · NCT05968482 · 74 enrolled · United States
  10. Apr 18, 2024HALEON’s first study: phase 4 study in PainNew to HALEONHALEON · NCT06379893 · 196 enrolled · United States, Poland
  11. Dec 6, 2024Phase 1 study in Healthy VolunteerAmzell · NCT06729073 · 34 enrolled · Germany

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 11 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT06729073Healthy Volunteer · Germany1CompletedAmzellJun 10, 202534
NCT06379893Pain · United States, Poland4CompletedHALEONOct 29, 2024196
NCT05968482Healthy · United States1CompletedAmzellDec 27, 202374
NCT03826550Keratosis, Actinic · United States3CompletedEncube Ethicals Pvt.Jun 30, 2018655
NCT03172780Osteoarthritis, Knee · India3CompletedViatrisDec 5, 20171,220
NCT02913521Osteoarthritis, Knee · Estonia, Latvia, Lithuania and more3CompletedAkornApr 2016934
NCT02596451Osteoarthritis · United States3CompletedGlenmark Pharmaceuticals Ltd. IndiaMar 20161,164
NCT02271854Myalgia · United States3CompletedNovartisDec 2014102
NCT01742663Keratosis, Actinic1CompletedSun Pharmaceutical IndustriesJul 2013435
NCT00426621Osteoarthritis, Knee · United States3CompletedNovartis420
NCT00171652Osteoarthritis · France, Germany3CompletedNovartis360

How it is read

Names in the registry

  • “Diclofenac Sodium Gel”, 3 entries
  • “Diclofenac sodium gel 1%”, 3 entries
  • “Voltaren Gel”, 1 entry
  • “Diclofenac sodium gel”, 1 entry
  • “Diclofenac sodium gel 3%”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.